Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Agents for Neuronal Excitability in Chronic SCI
NCT05708274Phase 1Completed
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Jan 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cyproheptadine, carbidopa + levodopa and atomoxetine in spinal cord injury (SCI), sponsored by James J. Peters Veterans Affairs Medical Center. Started Jan 2023; status: completed.
02
Drugs
cyproheptadinecarbidopa + levodopaatomoxetine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05708274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05708274.